Published on July 11, 2016
Professor Lisa Walker, genetics consultant in oncology at Oxford University Hospitals, explains the effect that had in healthcare the revelation by Angelina Jolie that she had undergone risk-reducing surgery for breast cancer. Angelina, like many women, is a carrier of BRCA1 mutation that highly increases the risk of developing this type of cancer. The actress lost her mother, grandmother and aunt to the disease.
The interview was recorded in Madrid (Spain) at the Familial Cancer Congress organized by the Spanish National Cancer Research Centre (CNIO). CNIO and Patient Power Europe have signed a partnership with the goal to empower cancer patients.